loadpatents
name:-0.024547100067139
name:-0.022522211074829
name:-0.00049304962158203
Wissner; Allan Patent Filings

Wissner; Allan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wissner; Allan.The latest application filed is for "protein tyrosine kinase enzyme inhibitors".

Company Profile
0.24.17
  • Wissner; Allan - Ardsley NY
  • WISSNER; Allan - Westchester NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Protein tyrosine kinase enzyme inhibitors
Grant 7,982,043 - Wissner , et al. July 19, 2
2011-07-19
Substituted 3-cyanoquinolines
Grant RE42,376 - Wissner , et al. May 17, 2
2011-05-17
Substituted 3-cyanopyridines as protein kinase inhibitors
Grant 7,781,591 - Cole , et al. August 24, 2
2010-08-24
Protein Tyrosine Kinase Enzyme Inhibitors
App 20080319011 - Wissner; Allan ;   et al.
2008-12-25
Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof
App 20080293712 - WISSNER; Allan ;   et al.
2008-11-27
Assays to Identify Irreversibly Binding Inhibitors of Receptor Tyrosine Kinases
App 20080268460 - Loganzo; Frank ;   et al.
2008-10-30
Pyrimido[5,4-c] Quinoline-2, 4-Diamine Derivatives and Methods of Use Thereof
App 20080234300 - WISSNER; Allan ;   et al.
2008-09-25
Protein tyrosine kinase enzyme inhibitors
Grant 7,399,865 - Wissner , et al. July 15, 2
2008-07-15
Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors
App 20070299092 - Floyd Jr; Middleton Brawner ;   et al.
2007-12-27
Substituted Cyanopyridines as protein kinase inhibitors
App 20070287738 - Cole; Derek Cecil ;   et al.
2007-12-13
Substituted 3-cyanopyridines as protein kinase inhibitors
App 20070287708 - Cole; Derek Cecil ;   et al.
2007-12-13
Methods of synthesizing 6-alkylaminoquinoline derivatives
App 20060270670 - Chew; Warren ;   et al.
2006-11-30
Tricyclic protein kinase inhibitors
App 20060247217 - Berger; Dan M. ;   et al.
2006-11-02
Tricyclic protein kinase inhibitors
Grant 7,105,531 - Berger , et al. September 12, 2
2006-09-12
Protein tyrosine kinase enzyme inhibitors
App 20050059678 - Wissner, Allan ;   et al.
2005-03-17
3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
Grant 6,821,988 - Wissner , et al. November 23, 2
2004-11-23
3-Cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridin- es as protein kinase inhibitors
App 20040176602 - Boschelli, Diane Harris ;   et al.
2004-09-09
Tricyclic protein kinase inhibitors
App 20040110762 - Berger, Dan M. ;   et al.
2004-06-10
3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
Grant 6,689,772 - Boschelli , et al. February 10, 2
2004-02-10
Tricyclic protein kinase inhibitors
Grant 6,638,929 - Berger , et al. October 28, 2
2003-10-28
Tricyclic protein kinase inhibitors
Grant 6,608,048 - Tsou , et al. August 19, 2
2003-08-19
3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
App 20030149056 - Wissner, Allan ;   et al.
2003-08-07
Tricyclic protein kinase inhibitors
App 20030065180 - Tsou, Hwei-Ru ;   et al.
2003-04-03
3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
Grant 6,521,618 - Boschelli , et al. February 18, 2
2003-02-18
Substituted 3-cyano-[1.7], [1.5], and [1.8] naphthyridine inhibitors of tyrosine kinases
App 20020165229 - Wissner, Allan ;   et al.
2002-11-07
Substituted 3-cyano-[1.7],[1.5], and [1.8] naphthyridine inhibitors of tyrosine kinases
Grant 6,355,636 - Wissner , et al. March 12, 2
2002-03-12
3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridi- nes as protein kinase inhibitors
App 20020026052 - Boschelli, Diane Harris ;   et al.
2002-02-28
Tricyclic protein kinase inhibitors
App 20010051620 - Berger, Dan M. ;   et al.
2001-12-13
Substituted 3-cyanoquinolines
Grant 6,297,258 - Wissner , et al. October 2, 2
2001-10-02
Substituted 3-cyanoquinolines
Grant 6,288,082 - Wissner , et al. September 11, 2
2001-09-11
Substituted quinazoline derivatives
Grant 6,251,912 - Wissner , et al. June 26, 2
2001-06-26
Substituted 3-cyano quinolines
Grant 6,002,008 - Wissner , et al. Dec
1999-12-14
4-aminoquinazoline EGFR Inhibitors
Grant 5,760,041 - Wissner , et al.
1998-06-02
Retroviral protease inhibitors
Grant 5,430,150 - Trova , et al. July 4, 1
1995-07-04
Certain hyrdoxy-phosphinyl-oxy-phenylmethyl-imidazolium hydroxide inner salts as PAF antagonists
Grant 5,411,983 - Wissner , et al. May 2, 1
1995-05-02
Bis-aryl amide and urea antagonists of platelet activating factor
Grant 5,128,351 - Wissner July 7, 1
1992-07-07
Method of preparing bis-aryl amide and urea antagonists of platelet activating factor
Grant 5,077,409 - Wissner December 31, 1
1991-12-31
Antihypertensive phosphate derivatives
Grant 4,827,011 - Wissner , et al. May 2, 1
1989-05-02
Phosphocholine derivatives having antihypertensive action
Grant 4,640,913 - Wissner , et al. February 3, 1
1987-02-03
1-Hydroxymethyl-1-oxo-prostane derivatives of the A.sub.2 series
Grant 4,212,969 - Wissner July 15, 1
1980-07-15
1-Hydroxymethyl-1-oxo-prostane derivatives of the A.sub.1 series
Grant 4,197,245 - Wissner April 8, 1
1980-04-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed